$162.43
▼ $-2.43
(-1.47%)
Vol 1.8M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$37.1B
ROE
-183.5%
Margin
-264.8%
D/E
77.03
Beta
1.10
52W
$60–$213
Wall Street Consensus
26 analysts · Apr 20269
Strong Buy
16
Buy
1
Hold
0
Sell
0
Strong Sell
96.2%
Buy Rating
Price Chart
Similar Stocks
GILD
Gilead Sciences Inc
P/E 18.8
$152.3B
VRTX
Vertex Pharmaceuticals Inc
P/E 31.3
$115.0B
REGN
Regeneron Pharmaceuticals Inc
P/E 17.7
$81.1B
ALNY
Alnylam Pharmaceuticals Inc
P/E 1205.9
$52.5B
NTRA
Natera Inc
$31.7B
BIIB
Biogen Inc
P/E 16.0
$25.8B
UTHR
United Therapeutics Corp
P/E 16.5
$21.0B
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
Earnings
Beat rate: 0.0%
Next Report
May 06, 2026
EPS Estimate: $-1.02
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.02 | — | — |
| Dec 2025 | $-1.32 | $-1.54 | $-0.22 |
| Sep 2025 | $-1.37 | $-1.75 | $-0.38 |
| Jun 2025 | $-1.32 | $-1.70 | $-0.38 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -195.4% | -195.4% | -195.4% | -183.5% | -183.5% | -183.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -299.5% | -259.8% | -259.8% | -264.8% | -264.8% | -264.8% |
| Gross Margin | 73.9% | 75.7% | 75.7% | 76.5% | 76.5% | 76.5% |
| D/E Ratio | 58.22 | 45.14 | 45.14 | 59.71 | 77.03 | 77.03 |
| Current Ratio | 6.68 | 6.68 | 6.68 | 4.63 | 4.63 | 4.63 |
Key Ratios
ROA (TTM)
-54.6%
P/S (TTM)
83.03
P/B
43.3
EPS (TTM)
$-6.18
CF/Share
$-5.17
Rev Growth 3Y
+24.5%
52W High
$212.75
52W Low
$60.40
$60.40
52-Week Range
$212.75
How does INSM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
INSM valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
83.0
▲
546%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
43.3
▲
1659%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
INSM profitability vs Biotechnology peers
ROE
-183.6%
▼
173%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-264.8%
▲
8%
above
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
76.5%
▼
3%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-54.6%
▼
17%
below
peers
(-46.7%)
vs Peers
vs Industry
Below avg
INSM financial health vs Biotechnology peers
D/E ratio
77.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
4.6
▲
4%
above
peers
(4.4)
vs Peers
vs Industry
In line
Beta
1.1
▲
14%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
INSM fundamentals radar
INSM
Peer median
Industry
INSM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio